|   Seminal Plasma Inhibin (67-94) (human)结构式   | 常用名 | Seminal Plasma Inhibin (67-94) (human) | 英文名 | Seminal Plasma Inhibin (67-94) (human) | 
|---|---|---|---|---|
| CAS号 | 96182-95-5 | 分子量 | 3299.856 | |
| 密度 | 1.4±0.1 g/cm3 | 沸点 | 2786.4±65.0 °C at 760 mmHg | |
| 分子式 | C150H240N36O43S2 | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | 1639.0±34.3 °C | |
| 符号 |   GHS08 | 信号词 | Danger | 
| 英文名 | Seminal Plasma Inhibin (67-94) (human) | 
|---|---|
| 英文别名 | 更多 | 
| 密度 | 1.4±0.1 g/cm3 | 
|---|---|
| 沸点 | 2786.4±65.0 °C at 760 mmHg | 
| 分子式 | C150H240N36O43S2 | 
| 分子量 | 3299.856 | 
| 闪点 | 1639.0±34.3 °C | 
| 精确质量 | 3297.714111 | 
| LogP | -5.48 | 
| 蒸汽压 | 0.0±0.3 mmHg at 25°C | 
| 折射率 | 1.633 | 
| 符号 |   GHS08 | 
|---|---|
| 信号词 | Danger | 
| 危害声明 | H360 | 
| 警示性声明 | P201-P308 + P313 | 
| 个人防护装备 | Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges | 
| 危险品运输编码 | NONH for all modes of transport | 
| PSP94, an upstream signaling mediator of prostasin found highly elevated in ovarian cancer. Cell Death Dis. 5 , e1407, (2014) Ovarian cancer is a leading cause of cancer death as diagnosis is frequently delayed to an advanced stage. Effective biomarkers and screening strategies for early detection are urgently needed. In the... | |
| MSMB gene variant alters the association between prostate cancer and number of sexual partners. Prostate 73(16) , 1803-9, (2013) Recently, a genetic variant (rs10993994) in the MSMB gene associated with prostate cancer (PCa) risk was shown to correlate with reduced prostate secretory protein of 94 amino acids (PSP94) levels. Al... | |
| Prostate secretory protein PSP-94 decreases tumor growth and hypercalcemia of malignancy in a syngenic in vivo model of prostate cancer. Cancer Res. 63(9) , 2072-8, (2003) Prostate cancer is a common malignancy affecting men, which is often associated with skeletal metastases resulting in significant morbidity and mortality. In this hormone-dependent cancer, low levels ... | 
| N-({(3S,6S,9S,12R,17R,20S,23S,26S,29S,32S,35S,38S,41S,44S,49aS)-3,6,20,38,41-Pentakis(4-aminobutyl)-26-[(2S)-2-butanyl]-35-(2-carboxyethyl)-44-(carboxymethyl)-23-(4-hydroxybenzyl)-9-[(1R)-1-hydroxyeth ;yl]-17-[(L-isoleucyl-L-phenylalanyl-L-lysyl-L-lysyl-L-α-glutamyl-L-α-aspartyl)amino]-29,32-diisopropyl-1,4,7,10,18,21,24,27,30,33,36,39,42,45-tetradecaoxohexatetracontahydro-1H-pyrrolo[2,1-p][ 1,2,5,8,11,14,17,20,23,26,29,32,35,38,41,44] | 
| L-Isoleucine, N-[[(3S,6S,9S,12R,17R,20S,23S,26S,29S,32S,35S,38S,41S,44S,49aS)-17-[[(2S,5S,8S,11S,14S,17S,18S)-17-amino-8,11-bis(4-aminobutyl)-5-(2-carboxyethyl)-2-(carboxymethyl)-18-methyl-1,4,7,10,13,16-hexaoxo-14-(phenylmethyl)-3,6,9,12,15-pentaazaeicos-1-yl]amino]-3,6,20,38,41-pentakis(4-aminobutyl)-35-(2-carboxyethyl)-44-(carboxymethyl)hexatetracontahydro-9-[(1R)-1-hydroxyethyl]-23-[(4-hydroxyphenyl)methyl]-29,32-bis(1-methylethyl)-26-[ |